Mar 17, 2017 13:00 pm UTC| Business
Final Purchase Order Expected During Third Quarter 2017 Company Announces Change in Management HAUPPAUGE, N.Y., March 17, 2017 -- Orbit International Corp. (OTC PINK:ORBT), an electronics manufacturer and software...
Mar 17, 2017 13:00 pm UTC| Business
CEDAR RAPIDS, Iowa, March 17, 2017 -- Tax Day is just around the corner, and millennials who waited until the last minute are phoning home. According to a recent ORC International Survey conducted for TaxAct among...
WisdomTree Announces U.S. Domestic Economy Fund (WUSA) and U.S. Export and Multinational Fund (WEXP)
Mar 17, 2017 13:00 pm UTC| Business
Formerly WisdomTree Strong Dollar U.S. Equity Fund (USSD) andWisdomTree Weak Dollar U.S. Equity Fund (USWD) ETFs to provide access to investment themes based on new Presidential regime NEW YORK, March 17, 2017 --...
Orbit International Announces Repurchase of 156,450 Shares of Its Common Stock
Mar 17, 2017 12:45 pm UTC| Business
HAUPPAUGE, N.Y., March 17, 2017 -- Orbit International Corp. (OTC PINK:ORBT), an electronics manufacturer and software solution provider, today announced that it repurchased, in the aggregate, 156,450 shares of its...
DHT Holdings, Inc. announces sale of its oldest VLCC
Mar 17, 2017 12:36 pm UTC| Business
HAMILTON, BERMUDA, March 17, 2017 - DHT Holdings, Inc. (NYSE:DHT) ("DHT") announced that it has entered into agreement to sell the DHT Ann, a 2001 built VLCC, for $24.8 million. The sale is in accordance with the...
Sarepta Therapeutics Announces Presentations at the 2017 MDA Scientific Conference
Mar 17, 2017 12:30 pm UTC| Business
CAMBRIDGE, Mass., March 17, 2017 -- Sarepta Therapeutics, Inc. (NASDAQ:SRPT), a commercial-stage biopharmaceutical company focused on the discovery and development of unique RNA-targeted therapeutics for the treatment...
Dermira to Highlight Data for Three Clinical Programs at Annual Maui Derm Meeting
Mar 17, 2017 12:30 pm UTC| Business
New data for the Axillary Sweating Daily Diary patient-reported outcome instrument from the glycopyrronium tosylate Phase 2 trial in primary axillary hyperhidrosis to be highlighted Additional data from the CIMPACT Phase 3...